Literature DB >> 8108136

Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.

C C Chang1, J Zhang, L Lombardi, A Neri, R Dalla-Favera.   

Abstract

The NFKB-2 gene (previously LYT-10, NF-kappa Bp100 or NF-kappa Bp97) codes for a NF-kappa B/rel related protein which is highly homologous to NFKB-1 (previously NF-kappa Bp105) within its rel, poly-glycine and ankyrin domains. The NFKB-2 gene is a candidate proto-oncogene since it is involved in lymphoma-associated chromosomal aberrations. In order to gain insight into the physiological function and role in tumorigenesis of NFKB-2, we have analysed its mechanism of expression and role in transcriptional regulation. We report that, contrary to previous studies, a single 3.2 kb mRNA species and its 100 kD (p100) primary translation product is detectable in all cell types tested. A second NFKB-2 protein, p52, corresponding to the amino-terminal half (rel domain) of NFKB-2 p100, is detectable in the same cell types and derives from the post-translational processing of p100. While p100 is constitutively localized in the cytoplasm, NF-kappa B induction by TPA treatment of Hela cells is associated with cytoplasmic/nuclear translocation of NFKB-2 p52 and its appearance within DNA-binding NF-kappa B complexes. NFKB-2 p52 differs from NFKB-1p50 in its differential affinity for kappa B sequences: by itself it binds H2/HLA-kappa B sites more efficiently than HIV/IgK-kappa B sites, while it can bind both sites efficiently when complexed with Rel-A(p65). Transient co-transfection of expression and reporter plasmids in cells devoid of endogenous NF-kappa B activity showed that p52 has no intrinsic transcriptional activation capabilities: it can stimulate Rel-A(p65)-driven transcription by formation of p65/p52 heterodimers, whereas, overexpressed, it down-regulates p65-dependent transcription by formation of inactive p52/p52 homodimers. These results indicate that the NFKB-2 gene codes for an inducible NF-kappa B transcription factor with the capability of differentially regulating NF-kappa B transcription depending on its abundance in the nucleus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8108136

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.

Authors:  Tzu-Pei Chang; Vladimir Poltoratsky; Ivana Vancurova
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

2.  Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators.

Authors:  C C Chang; J Zhang; L Lombardi; A Neri; R Dalla-Favera
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

3.  Glutamate-dependent activation of NF-kappaB during mouse cerebellum development.

Authors:  L Guerrini; A Molteni; T Wirth; B Kistler; F Blasi
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

4.  Structure of the human NF-kappaB p52 homodimer-DNA complex at 2.1 A resolution.

Authors:  P Cramer; C J Larson; G L Verdine; C W Müller
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

5.  Structural and functional characterization of the promoter regions of the NFKB2 gene.

Authors:  L Lombardi; P Ciana; C Cappellini; D Trecca; L Guerrini; A Migliazza; A T Maiolo; A Neri
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

6.  Constitutive production of NF-kappaB2 p52 is not tumorigenic but predisposes mice to inflammatory autoimmune disease by repressing Bim expression.

Authors:  Zhe Wang; Baochun Zhang; Liqun Yang; Jane Ding; Han-Fei Ding
Journal:  J Biol Chem       Date:  2008-02-15       Impact factor: 5.157

7.  Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells.

Authors:  R Hrdlicková; J Nehyba; H R Bose
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

8.  Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways.

Authors:  Kelly L Hamilton; Stephanie A Sheehan; Edward P Retzbach; Clinton A Timmerman; Garret B Gianneschi; Patrick J Tempera; Premalatha Balachandran; Gary S Goldberg
Journal:  J Cancer Res Clin Oncol       Date:  2020-11-17       Impact factor: 4.553

9.  Conservation and divergence of vulnerability and responses to stressors between human and mouse astrocytes.

Authors:  Jiwen Li; Lin Pan; William G Pembroke; Jessica E Rexach; Marlesa I Godoy; Michael C Condro; Alvaro G Alvarado; Mineli Harteni; Yen-Wei Chen; Linsey Stiles; Angela Y Chen; Ina B Wanner; Xia Yang; Steven A Goldman; Daniel H Geschwind; Harley I Kornblum; Ye Zhang
Journal:  Nat Commun       Date:  2021-06-25       Impact factor: 17.694

10.  RNAi-mediated c-Rel silencing leads to apoptosis of B cell tumor cells and suppresses antigenic immune response in vivo.

Authors:  Wenzhi Tian; Hsiou-Chi Liou
Journal:  PLoS One       Date:  2009-04-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.